Back to Journals » ClinicoEconomics and Outcomes Research » Volume 10

Cost–consequence analysis of fluticasone furoate/vilanterol 92/22 mcg for the management of COPD in the Spanish NHS

Total article views   HTML views PDF downloads Totals
7,337 Dovepress* 6,930+ 1,063 7,993
PubMed Central* 407 114 521
Totals 7,337 1,177 8,514
*Since 5 September 2018

View citations on PubMed Central and Google Scholar